Literature DB >> 16598329

Is early mortality related to timing of surgery after fracture femur in the elderly?

Abdallah Al-Omran1, Mir Sadat-Ali.   

Abstract

OBJECTIVE: The purpose of this study is to review the outcome of fracture femur in elderly patients (>65 years), and to identify cause or causes of mortality.
METHODS: Between January 1996 and December 2002, 115 patients over 65 years were admitted and operated at King Fahd University Hospital, Al-Khobar. Fifty-six of patients suffered with femoral fractures. Demographic data collected included age, gender, site of fracture, co-morbidities, delay in surgery, duration of surgery, implant used and Anesthesia Society of America scoring (ASA). A minimum follow up of 12 months was considered important for inclusion in the study. Patients remained alive were assessed for their functional independence.
RESULTS: The data of 48 patients were gathered for analysis. There were 31 males and 17 females with a mean age of 76.5 years (age range 65-101 years). The mean follow up was 32.8 months (12-84 months +/- SD 17.81). There were 32 fractures of the trochanteric area. The average delay in surgery was 112 hours (24-280 hours). At the end of 24 months: 13 (27%) were dead and 28 (80%) were functionally independent similar to pre-injury status. There was statistical significance between the ASA score and the mortality (p<0.005). However, mortality significantly higher in patients who underwent surgery under general anesthesia p<0.05.
CONCLUSION: Our data indicate that the mortality in the elderly is not related to the delay in surgery. The significant factors to early demise of patients were high ASA score, and the type of anesthesia used during surgery.

Entities:  

Mesh:

Year:  2006        PMID: 16598329

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  8 in total

1.  In-hospital mortality from femoral shaft fracture depends on the initial delay to fracture fixation and Injury Severity Score: a retrospective cohort study from the NTDB 2002-2006.

Authors:  Robert Victor Cantu; Sara Catherine Graves; Kevin F Spratt
Journal:  J Trauma Acute Care Surg       Date:  2014-06       Impact factor: 3.313

Review 2.  Osteoporotic hip and vertebral fractures in the Arab region: a systematic review.

Authors:  M Barake; R El Eid; S Ajjour; M Chakhtoura; L Meho; T Mahmoud; J Atieh; A M Sibai; G El-Hajj Fuleihan
Journal:  Osteoporos Int       Date:  2021-04-07       Impact factor: 4.507

3.  Do osteoporosis-related vertebral fractures precede hip fractures?

Authors:  Mir Sadat-Ali; Abid Hussain Gullenpet; Md Quamar Azam; Ammar K Al-Omran
Journal:  World J Orthop       Date:  2012-12-18

4.  Genetic influence of candidate osteoporosis genes in saudi arabian population: a pilot study.

Authors:  Mir Sadat-Ali; Haifa A Al-Turki
Journal:  J Osteoporos       Date:  2012-04-01

5.  Are we missing osteoporosis-related vertebral fractures in men?

Authors:  Mir Sadat-Ali; Abid Hussain Gullenpet; Haifa A Al-Turki; Tamar W Abdulrahman; Abdulmohsen H Al-Elq; Mohammed Quamar Azzam; Hadia Al-Shammary; Abdallah S Al-Omran; Abdallah A Al-Othman
Journal:  Asian Spine J       Date:  2011-05-02

6.  The timing of surgery and mortality in elderly hip fractures: A retrospective, multicenteric cohort study.

Authors:  Hyuk Joong Choi; Euichung Kim; Young Jeon Shin; Bo Youl Choi; Young Ho Kim; Tae Ho Lim
Journal:  Indian J Orthop       Date:  2014-11       Impact factor: 1.251

7.  Morbidity and mortality after fragility hip fracture in a Saudi Arabian population: Report from a single center.

Authors:  Mir Sadat-Ali; Moaad Alfaraidy; Abdulaziz AlHawas; Ahmed Abdallah Al-Othman; Dakheel A Al-Dakheel; Badar K Tayara
Journal:  J Int Med Res       Date:  2017-05-08       Impact factor: 1.671

8.  Effect of regional versus general anaesthesia on postoperative delirium in elderly patients undergoing surgery for hip fracture: a systematic review.

Authors:  Vanisha Patel; Rita Champaneria; Janine Dretzke; Joyce Yeung
Journal:  BMJ Open       Date:  2018-12-04       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.